|
⚲
|
| Keyboard |
| DeFrancesco Lisa
✚
|
|
|---|---|
| CIK # | 0001846325 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001846325] | |
| 4 | [0001846325] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| DeFrancesco Lisa | |
| Lexicon Pharmaceuticals Inc | |
| Intercept Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 128,190 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 24,674 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 128,190 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Tax withheld | 74,572 | $1.47 | 109,621 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 24,674 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 386,300 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-12 | Grant | 257,530 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-02-28 | Option exercise | 24,673 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2025-02-28 | Tax withheld | 9,096 | $0.67 | 6,094 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2025-02-28 | Option exercise | 24,673 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-02-13 | Grant | 384,570 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 576,850 | $0.00 | |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock
|
2021-12-31 | Tax withheld | 542 | $16.29 | 8,829 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock
|
2021-09-30 | Tax withheld | 204 | $14.85 | 3,029 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock
|
2021-09-01 | Tax withheld | 538 | $15.05 | 8,097 |